Literature DB >> 6331303

Virus drug-resistance: mechanisms and consequences.

B A Larder, G Darby.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6331303     DOI: 10.1016/0166-3542(84)90023-8

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  22 in total

Review 1.  Randomised placebo controlled trials in HIV infection: to be or not to be?

Authors:  K Gelmon; I V Weller
Journal:  Genitourin Med       Date:  1989-06

2.  Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase.

Authors:  V R Prasad; I Lowy; T de los Santos; L Chiang; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Activity of the cytomegalovirus genome in the presence of PPi analogs.

Authors:  B Wahren; U Rudén; H Gadler; B Oberg; B Eriksson
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

4.  Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir.

Authors:  B A Larder; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene.

Authors:  H J Field; D M Coen
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.

Authors:  E L Hill; G A Hunter; M N Ellis
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

7.  Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.

Authors:  J Bestman-Smith; I Schmit; B Papadopoulou; G Boivin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 8.  Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.

Authors:  D Ormrod; L J Scott; C M Perry
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 9.  Persistent herpes simplex virus infection and mechanisms of virus drug resistance.

Authors:  H J Field
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

Review 10.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.